These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 4069054)
1. Oestrogen receptors in focal nodular hyperplasia of the liver. Hunt RF; Sali A; Kune GA Med J Aust; 1985 Nov; 143(11):519-20. PubMed ID: 4069054 [TBL] [Abstract][Full Text] [Related]
2. Focal nodular hyperplasia of the liver and contraceptive steroids. St Omer FB; Iozzo RV; Casetti P; Dellarolle AC Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):319-21. PubMed ID: 696209 [TBL] [Abstract][Full Text] [Related]
3. Oral contraceptives and focal nodular hyperplasia of the liver. Hagay ZJ; Leiberman RJ; Katz M; Witznitzer A Arch Gynecol Obstet; 1988; 243(4):231-4. PubMed ID: 3223780 [TBL] [Abstract][Full Text] [Related]
4. [Oral contraceptives and benign tumorous conditions of the liver (author's transl)]. Lesch R; Hoppe-Seyler P; Heissmeyer HH; Hoensch D; Jenss H; Wimmer B; Wenz W Radiologe; 1980 Dec; 20(12):565-76. PubMed ID: 7208890 [TBL] [Abstract][Full Text] [Related]
5. Focal nodular hyperplasia of the liver: a clinicopathologic study and review of the literature. Knowles DM; Wolff M Hum Pathol; 1976 Sep; 7(5):533-45. PubMed ID: 964980 [TBL] [Abstract][Full Text] [Related]
6. Oestrogen hormone receptors in focal nodular hyperplasia. Chandrasegaram MD; Shah A; Chen JW; Ruszkiewicz A; Astill DS; England G; Raju RS; Neo EL; Dolan PM; Tan CP; Brooke-Smith M; Wilson T; Padbury RT; Worthley CS HPB (Oxford); 2015 Jun; 17(6):502-7. PubMed ID: 25728618 [TBL] [Abstract][Full Text] [Related]
7. [Multiple nodular hyperplasia of liver associated with oral contraceptives (author's transl)]. Roschlau G Zentralbl Allg Pathol; 1977; 121(6):517-21. PubMed ID: 607696 [TBL] [Abstract][Full Text] [Related]
8. [A rare form of benign tumor of the liver possibly related to the use of oral contraceptives: focal pediculated nodular hyperplasia]. Brouquet J; Chameaud J; Vire O; Fabre P; Catanzano G; Baudet JH Rev Fr Gynecol Obstet; 1985; 80(8-9):621-7. PubMed ID: 2997901 [TBL] [Abstract][Full Text] [Related]
9. Hepatic tumors and oral contraceptives: surgical management. Gonzalez F; Marks C J Surg Oncol; 1985 Jul; 29(3):193-7. PubMed ID: 3001424 [TBL] [Abstract][Full Text] [Related]
10. [Estrogen and progesterone receptors in human liver: does their study contribute to a better understanding of benign contraceptive-associated liver tumors?]. Pirovino M; Wälti E; Akovbiantz A; Arrenbrecht S; Zava D; Bühler H; Schmid M Schweiz Med Wochenschr; 1986 Jul; 116(29):971-3. PubMed ID: 3020682 [TBL] [Abstract][Full Text] [Related]
11. Failure of hepatic adenomas (HCA) to regress after discontinuance of oral contraceptives. An association with focal nodular hyperplasia (FNH) and uterine leiomyoma. Marks WH; Thompson N; Appleman H Ann Surg; 1988 Aug; 208(2):190-5. PubMed ID: 2840865 [TBL] [Abstract][Full Text] [Related]
12. Enlarged focal nodular hyperplasia of the liver under the influence of oral contraceptives. Kubota T; Shimizu K; Sonoyama T; Ikeda E; Kurioka H; Ouchi T; Suyama Y; Hosokawa Y; Yamagishi H Hepatogastroenterology; 2001; 48(42):1736-9. PubMed ID: 11813612 [TBL] [Abstract][Full Text] [Related]
13. Increased UDP-glucuronyltransferase in putative preneoplastic foci of human liver after long-term use of oral contraceptives. Fischer G; Schauer A; Hartmann H; Bock KW Naturwissenschaften; 1985 May; 72(5):277-8. PubMed ID: 3925352 [TBL] [Abstract][Full Text] [Related]